[1] DU DD, LIU B, SHI W, et al.Analysis of influenza pathogen surveillance in Ankang from 2016 to 2018[J]. J Med Pest Control(医学动物防制), 2020, 36(11): 1038-1041. [2] FU YJ.Effects of different traditional Chinese medicines on TLR7/NF-κB signaling pathway in mice infected with influenza virus FM1 in normal environment and damp-heat environment[D]. Guangzhou: Jinan University, 2021. [3] JIN Y.Research on the evolution of major subtypes in influenza A virus[D]. Beijing: Academy of Military Sciences, 2015. [4] WEI X, NARASIMHAN H, ZHU B, et al.Host recovery from respiratory viral infection[J]. Annu Rev Immunol, 2023, 41: 277-300. [5] ZHU Q, PAN J, XU J, et al.Research progress on Shufeng Jiedu Capsules in treatment of respiratory infectious diseases[J]. Chinese Traditional and Herbal Drugs(中草药), 2022, 53(11): 3557-3563. [6] BAO YY, GAO YJ, SHI YJ, et al.Study on broad-spectrum antiviral effect of Shufeng Jiedu Capsules[J]. New Chinese Medicine(新中医), 2019, 51(12): 5-8. [7] XU YL, XUE YL, ZHANG HH, et al.Clinical observation on treatment of acute upper respiratory infection of wind-heat syndrome with Shufeng Jiedu Capsules[J]. Journal of Traditional Chinese Medicine(中医杂志), 2015, 56(8): 676-679. [8] XI ZQ, ZHOU JZ, MEI JQ, et al.Clinical study about the effect on the fever caused by viral upper respiratory tract infection[J]. Chinese Medicine Modern Distance Education of China(中国中医药现代远程教育), 2010, 8(17): 162-164. [9] CHEN YB, LIN L, WU MH, et al.Research ideas and methods of “diaphoresis,harmonizing,clearing and purgative, expelling pathogens from both interior and exterior ”in treatment of influenza[J]. Liaoning Journal of Traditional Chinese Medicine(辽宁中医杂志), 2018, 45(1): 50-52. [10] YANG C.Progress and prospects of the application of Chinese medicine in influenza control[J]. Journal of Traditional Chinese Medicine Management(中医药管理杂志), 2023, 31(6): 226-228. [11] XIE P, WANG CQ, YE YH, et al.Virtual screening of the active ingredients of Shufeng Jiedu Capsule for COVID-19 based on molecular docking and network pharmacology[J]. Journal of Pharmaceutical Research(药学研究), 2021, 40(9): 590-597, 604. [12] YUAN Y, LIAO Q, XUE M, et al.Shufeng Jiedu Capsules alleviate lipopolysaccharide-induced acute lung inflammatory injury via activation of GPR18 by verbenalin[J]. Cell Physiol Biochem, 2018, 50(2): 629-639. [13] XIA L, SHI Y, SU J, et al.Shufeng Jiedu, a promising herbal therapy for moderate COVID-19:Antiviral and anti-inflammatory properties, pathways of bioactive compounds, and a clinical real-world pragmatic study[J]. Phytomedicine, 2021, 85: 153390. [14] BAI J, ZHANG XZ, LIU MX, et al.Effect and mechanism of Jinzhen Oral Liquid on influenza virus pneumonia in mice[J]. Drugs & Clinic(现代药物与临床), 2023, 38(3): 499-504. [15] Keogh B, Parker A E.Toll-like receptors as targets for immune disorders[J]. Trends Pharmacol Sci, 2011, 32(7): 435-442. [16] GALIANA-ARNOUX D, IMLER JL.Toll-like receptors and innate antiviral immunity[J]. Tissue Antigens, 2006, 67(4): 267-276. |